SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in patients with hemoglobin SC, a milder form of sickle cell disease (SCD), a ...

Hydroxyurea is generally contraindicated in patients with sickle cell disease who become or plan to become pregnant, but post-marketing safety data suggest that treatment continuation is safe. The ...

Large European cohort data suggest hydroxyurea pregnancy exposure in sickle cell disease is not linked to congenital ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Hydroxyurea conferred benefit to children and adults with hemoglobin SC disease, according to study ...